Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Market Overview

1.1 Non-sterile Liquid Product Introduction

1.2 Global Non-sterile Liquid Market Size Forecast

1.2.1 Global Non-sterile Liquid Sales Value (2019-2030)

1.2.2 Global Non-sterile Liquid Sales Volume (2019-2030)

1.2.3 Global Non-sterile Liquid Sales Price (2019-2030)

1.3 Non-sterile Liquid Market Trends & Drivers

1.3.1 Non-sterile Liquid Industry Trends

1.3.2 Non-sterile Liquid Market Drivers & Opportunity

1.3.3 Non-sterile Liquid Market Challenges

1.3.4 Non-sterile Liquid Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Non-sterile Liquid Players Revenue Ranking (2023)

2.2 Global Non-sterile Liquid Revenue by Company (2019-2024)

2.3 Global Non-sterile Liquid Players Sales Volume Ranking (2023)

2.4 Global Non-sterile Liquid Sales Volume by Company Players (2019-2024)

2.5 Global Non-sterile Liquid Average Price by Company (2019-2024)

2.6 Key Manufacturers Non-sterile Liquid Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Non-sterile Liquid Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Non-sterile Liquid

2.9 Non-sterile Liquid Market Competitive Analysis

2.9.1 Non-sterile Liquid Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Non-sterile Liquid Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-sterile Liquid as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Solution

3.1.2 Suspension

3.1.3 Gel

3.1.4 Syrup

3.1.5 Ethanolic Liquid

3.2 Global Non-sterile Liquid Sales Value by Type

3.2.1 Global Non-sterile Liquid Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Non-sterile Liquid Sales Value, by Type (2019-2030)

3.2.3 Global Non-sterile Liquid Sales Value, by Type (%) (2019-2030)

3.3 Global Non-sterile Liquid Sales Volume by Type

3.3.1 Global Non-sterile Liquid Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Non-sterile Liquid Sales Volume, by Type (2019-2030)

3.3.3 Global Non-sterile Liquid Sales Volume, by Type (%) (2019-2030)

3.4 Global Non-sterile Liquid Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Human Medication

4.1.2 Nutraceuticals

4.1.3 Cosmetics

4.1.4 Medical Devices

4.2 Global Non-sterile Liquid Sales Value by Application

4.2.1 Global Non-sterile Liquid Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Non-sterile Liquid Sales Value, by Application (2019-2030)

4.2.3 Global Non-sterile Liquid Sales Value, by Application (%) (2019-2030)

4.3 Global Non-sterile Liquid Sales Volume by Application

4.3.1 Global Non-sterile Liquid Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Non-sterile Liquid Sales Volume, by Application (2019-2030)

4.3.3 Global Non-sterile Liquid Sales Volume, by Application (%) (2019-2030)

4.4 Global Non-sterile Liquid Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Non-sterile Liquid Sales Value by Region

5.1.1 Global Non-sterile Liquid Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Non-sterile Liquid Sales Value by Region (2019-2024)

5.1.3 Global Non-sterile Liquid Sales Value by Region (2025-2030)

5.1.4 Global Non-sterile Liquid Sales Value by Region (%), (2019-2030)

5.2 Global Non-sterile Liquid Sales Volume by Region

5.2.1 Global Non-sterile Liquid Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Non-sterile Liquid Sales Volume by Region (2019-2024)

5.2.3 Global Non-sterile Liquid Sales Volume by Region (2025-2030)

5.2.4 Global Non-sterile Liquid Sales Volume by Region (%), (2019-2030)

5.3 Global Non-sterile Liquid Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Non-sterile Liquid Sales Value, 2019-2030

5.4.2 North America Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Non-sterile Liquid Sales Value, 2019-2030

5.5.2 Europe Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Non-sterile Liquid Sales Value, 2019-2030

5.6.2 Asia Pacific Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Non-sterile Liquid Sales Value, 2019-2030

5.7.2 South America Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Non-sterile Liquid Sales Value, 2019-2030

5.8.2 Middle East & Africa Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Non-sterile Liquid Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Non-sterile Liquid Sales Value

6.2.1 Key Countries/Regions Non-sterile Liquid Sales Value, 2019-2030

6.2.2 Key Countries/Regions Non-sterile Liquid Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Non-sterile Liquid Sales Value, 2019-2030

6.3.2 United States Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Non-sterile Liquid Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Non-sterile Liquid Sales Value, 2019-2030

6.4.2 Europe Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Non-sterile Liquid Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Non-sterile Liquid Sales Value, 2019-2030

6.5.2 China Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

6.5.3 China Non-sterile Liquid Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Non-sterile Liquid Sales Value, 2019-2030

6.6.2 Japan Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Non-sterile Liquid Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Non-sterile Liquid Sales Value, 2019-2030

6.7.2 South Korea Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Non-sterile Liquid Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Non-sterile Liquid Sales Value, 2019-2030

6.8.2 Southeast Asia Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Non-sterile Liquid Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Non-sterile Liquid Sales Value, 2019-2030

6.9.2 India Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

6.9.3 India Non-sterile Liquid Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Nycomed

7.1.1 Nycomed Company Information

7.1.2 Nycomed Introduction and Business Overview

7.1.3 Nycomed Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Nycomed Non-sterile Liquid Product Offerings

7.1.5 Nycomed Recent Development

7.2 AbbVie

7.2.1 AbbVie Company Information

7.2.2 AbbVie Introduction and Business Overview

7.2.3 AbbVie Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.2.4 AbbVie Non-sterile Liquid Product Offerings

7.2.5 AbbVie Recent Development

7.3 Aenova

7.3.1 Aenova Company Information

7.3.2 Aenova Introduction and Business Overview

7.3.3 Aenova Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Aenova Non-sterile Liquid Product Offerings

7.3.5 Aenova Recent Development

7.4 APPCO

7.4.1 APPCO Company Information

7.4.2 APPCO Introduction and Business Overview

7.4.3 APPCO Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.4.4 APPCO Non-sterile Liquid Product Offerings

7.4.5 APPCO Recent Development

7.5 Atral Pharmaceutical

7.5.1 Atral Pharmaceutical Company Information

7.5.2 Atral Pharmaceutical Introduction and Business Overview

7.5.3 Atral Pharmaceutical Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Atral Pharmaceutical Non-sterile Liquid Product Offerings

7.5.5 Atral Pharmaceutical Recent Development

7.6 Aurigene Pharmaceutical Services

7.6.1 Aurigene Pharmaceutical Services Company Information

7.6.2 Aurigene Pharmaceutical Services Introduction and Business Overview

7.6.3 Aurigene Pharmaceutical Services Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Aurigene Pharmaceutical Services Non-sterile Liquid Product Offerings

7.6.5 Aurigene Pharmaceutical Services Recent Development

7.7 Biological E. Ltd.

7.7.1 Biological E. Ltd. Company Information

7.7.2 Biological E. Ltd. Introduction and Business Overview

7.7.3 Biological E. Ltd. Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Biological E. Ltd. Non-sterile Liquid Product Offerings

7.7.5 Biological E. Ltd. Recent Development

7.8 BioPlus Life Sciences

7.8.1 BioPlus Life Sciences Company Information

7.8.2 BioPlus Life Sciences Introduction and Business Overview

7.8.3 BioPlus Life Sciences Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.8.4 BioPlus Life Sciences Non-sterile Liquid Product Offerings

7.8.5 BioPlus Life Sciences Recent Development

7.9 Bora Pharmaceuticals

7.9.1 Bora Pharmaceuticals Company Information

7.9.2 Bora Pharmaceuticals Introduction and Business Overview

7.9.3 Bora Pharmaceuticals Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Bora Pharmaceuticals Non-sterile Liquid Product Offerings

7.9.5 Bora Pharmaceuticals Recent Development

7.10 Cambrex Corporation

7.10.1 Cambrex Corporation Company Information

7.10.2 Cambrex Corporation Introduction and Business Overview

7.10.3 Cambrex Corporation Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Cambrex Corporation Non-sterile Liquid Product Offerings

7.10.5 Cambrex Corporation Recent Development

7.11 JGL d.d.

7.11.1 JGL d.d. Company Information

7.11.2 JGL d.d. Introduction and Business Overview

7.11.3 JGL d.d. Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.11.4 JGL d.d. Non-sterile Liquid Product Offerings

7.11.5 JGL d.d. Recent Development

7.12 Mikart

7.12.1 Mikart Company Information

7.12.2 Mikart Introduction and Business Overview

7.12.3 Mikart Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Mikart Non-sterile Liquid Product Offerings

7.12.5 Mikart Recent Development

7.13 PharmaVision

7.13.1 PharmaVision Company Information

7.13.2 PharmaVision Introduction and Business Overview

7.13.3 PharmaVision Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.13.4 PharmaVision Non-sterile Liquid Product Offerings

7.13.5 PharmaVision Recent Development

7.14 Pierre Fabre

7.14.1 Pierre Fabre Company Information

7.14.2 Pierre Fabre Introduction and Business Overview

7.14.3 Pierre Fabre Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Pierre Fabre Non-sterile Liquid Product Offerings

7.14.5 Pierre Fabre Recent Development

7.15 TriRx Pharmaceutical Services

7.15.1 TriRx Pharmaceutical Services Company Information

7.15.2 TriRx Pharmaceutical Services Introduction and Business Overview

7.15.3 TriRx Pharmaceutical Services Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.15.4 TriRx Pharmaceutical Services Non-sterile Liquid Product Offerings

7.15.5 TriRx Pharmaceutical Services Recent Development

7.16 UI Pharmaceuticals

7.16.1 UI Pharmaceuticals Company Information

7.16.2 UI Pharmaceuticals Introduction and Business Overview

7.16.3 UI Pharmaceuticals Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.16.4 UI Pharmaceuticals Non-sterile Liquid Product Offerings

7.16.5 UI Pharmaceuticals Recent Development

7.17 Wasdell Group

7.17.1 Wasdell Group Company Information

7.17.2 Wasdell Group Introduction and Business Overview

7.17.3 Wasdell Group Non-sterile Liquid Sales, Revenue and Gross Margin (2019-2024)

7.17.4 Wasdell Group Non-sterile Liquid Product Offerings

7.17.5 Wasdell Group Recent Development

8 Industry Chain Analysis

8.1 Non-sterile Liquid Industrial Chain

8.2 Non-sterile Liquid Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Non-sterile Liquid Sales Model

8.5.2 Sales Channel

8.5.3 Non-sterile Liquid Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

List of Tables

Table 1. Non-sterile Liquid Market Trends

Table 2. Non-sterile Liquid Market Drivers & Opportunity

Table 3. Non-sterile Liquid Market Challenges

Table 4. Non-sterile Liquid Market Restraints

Table 5. Global Non-sterile Liquid Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Non-sterile Liquid Revenue Market Share by Company (2019-2024)

Table 7. Global Non-sterile Liquid Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Non-sterile Liquid Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Non-sterile Liquid Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Non-sterile Liquid Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Non-sterile Liquid Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Non-sterile Liquid

Table 13. Global Non-sterile Liquid Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-sterile Liquid as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Non-sterile Liquid Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Non-sterile Liquid Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Non-sterile Liquid Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Non-sterile Liquid Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Non-sterile Liquid Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Non-sterile Liquid Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Non-sterile Liquid Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Non-sterile Liquid Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Non-sterile Liquid Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Non-sterile Liquid Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Non-sterile Liquid Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Non-sterile Liquid Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Non-sterile Liquid Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Non-sterile Liquid Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Non-sterile Liquid Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Non-sterile Liquid Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Non-sterile Liquid Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Non-sterile Liquid Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Non-sterile Liquid Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Non-sterile Liquid Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Non-sterile Liquid Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Non-sterile Liquid Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Non-sterile Liquid Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Non-sterile Liquid Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Non-sterile Liquid Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Non-sterile Liquid Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Non-sterile Liquid Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Non-sterile Liquid Sales Value by Region (2019-2024) & (%)

Table 44. Global Non-sterile Liquid Sales Value by Region (2025-2030) & (%)

Table 45. Global Non-sterile Liquid Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Non-sterile Liquid Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Non-sterile Liquid Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Non-sterile Liquid Sales Volume by Region (2019-2024) & (%)

Table 49. Global Non-sterile Liquid Sales Volume by Region (2025-2030) & (%)

Table 50. Global Non-sterile Liquid Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Non-sterile Liquid Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Non-sterile Liquid Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Non-sterile Liquid Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Non-sterile Liquid Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Non-sterile Liquid Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Non-sterile Liquid Sales Volume, (2025-2030) & (K Units)

Table 57. Nycomed Company Information

Table 58. Nycomed Introduction and Business Overview

Table 59. Nycomed Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Nycomed Non-sterile Liquid Product Offerings

Table 61. Nycomed Recent Development

Table 62. AbbVie Company Information

Table 63. AbbVie Introduction and Business Overview

Table 64. AbbVie Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. AbbVie Non-sterile Liquid Product Offerings

Table 66. AbbVie Recent Development

Table 67. Aenova Company Information

Table 68. Aenova Introduction and Business Overview

Table 69. Aenova Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Aenova Non-sterile Liquid Product Offerings

Table 71. Aenova Recent Development

Table 72. APPCO Company Information

Table 73. APPCO Introduction and Business Overview

Table 74. APPCO Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. APPCO Non-sterile Liquid Product Offerings

Table 76. APPCO Recent Development

Table 77. Atral Pharmaceutical Company Information

Table 78. Atral Pharmaceutical Introduction and Business Overview

Table 79. Atral Pharmaceutical Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Atral Pharmaceutical Non-sterile Liquid Product Offerings

Table 81. Atral Pharmaceutical Recent Development

Table 82. Aurigene Pharmaceutical Services Company Information

Table 83. Aurigene Pharmaceutical Services Introduction and Business Overview

Table 84. Aurigene Pharmaceutical Services Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Aurigene Pharmaceutical Services Non-sterile Liquid Product Offerings

Table 86. Aurigene Pharmaceutical Services Recent Development

Table 87. Biological E. Ltd. Company Information

Table 88. Biological E. Ltd. Introduction and Business Overview

Table 89. Biological E. Ltd. Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Biological E. Ltd. Non-sterile Liquid Product Offerings

Table 91. Biological E. Ltd. Recent Development

Table 92. BioPlus Life Sciences Company Information

Table 93. BioPlus Life Sciences Introduction and Business Overview

Table 94. BioPlus Life Sciences Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. BioPlus Life Sciences Non-sterile Liquid Product Offerings

Table 96. BioPlus Life Sciences Recent Development

Table 97. Bora Pharmaceuticals Company Information

Table 98. Bora Pharmaceuticals Introduction and Business Overview

Table 99. Bora Pharmaceuticals Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Bora Pharmaceuticals Non-sterile Liquid Product Offerings

Table 101. Bora Pharmaceuticals Recent Development

Table 102. Cambrex Corporation Company Information

Table 103. Cambrex Corporation Introduction and Business Overview

Table 104. Cambrex Corporation Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Cambrex Corporation Non-sterile Liquid Product Offerings

Table 106. Cambrex Corporation Recent Development

Table 107. JGL d.d. Company Information

Table 108. JGL d.d. Introduction and Business Overview

Table 109. JGL d.d. Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. JGL d.d. Non-sterile Liquid Product Offerings

Table 111. JGL d.d. Recent Development

Table 112. Mikart Company Information

Table 113. Mikart Introduction and Business Overview

Table 114. Mikart Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Mikart Non-sterile Liquid Product Offerings

Table 116. Mikart Recent Development

Table 117. PharmaVision Company Information

Table 118. PharmaVision Introduction and Business Overview

Table 119. PharmaVision Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. PharmaVision Non-sterile Liquid Product Offerings

Table 121. PharmaVision Recent Development

Table 122. Pierre Fabre Company Information

Table 123. Pierre Fabre Introduction and Business Overview

Table 124. Pierre Fabre Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Pierre Fabre Non-sterile Liquid Product Offerings

Table 126. Pierre Fabre Recent Development

Table 127. TriRx Pharmaceutical Services Company Information

Table 128. TriRx Pharmaceutical Services Introduction and Business Overview

Table 129. TriRx Pharmaceutical Services Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. TriRx Pharmaceutical Services Non-sterile Liquid Product Offerings

Table 131. TriRx Pharmaceutical Services Recent Development

Table 132. UI Pharmaceuticals Company Information

Table 133. UI Pharmaceuticals Introduction and Business Overview

Table 134. UI Pharmaceuticals Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. UI Pharmaceuticals Non-sterile Liquid Product Offerings

Table 136. UI Pharmaceuticals Recent Development

Table 137. Wasdell Group Company Information

Table 138. Wasdell Group Introduction and Business Overview

Table 139. Wasdell Group Non-sterile Liquid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Wasdell Group Non-sterile Liquid Product Offerings

Table 141. Wasdell Group Recent Development

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Non-sterile Liquid Downstream Customers

Table 145. Non-sterile Liquid Distributors List

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Non-sterile Liquid Product Picture

Figure 2. Global Non-sterile Liquid Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Non-sterile Liquid Sales Volume (2019-2030) & (K Units)

Figure 5. Global Non-sterile Liquid Sales Price (2019-2030) & (US$/Unit)

Figure 6. Non-sterile Liquid Report Years Considered

Figure 7. Global Non-sterile Liquid Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Non-sterile Liquid Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-sterile Liquid Revenue in 2023

Figure 10. Non-sterile Liquid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Solution Picture

Figure 12. Suspension Picture

Figure 13. Gel Picture

Figure 14. Syrup Picture

Figure 15. Ethanolic Liquid Picture

Figure 16. Global Non-sterile Liquid Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Non-sterile Liquid Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Non-sterile Liquid Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 19. Global Non-sterile Liquid Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Non-sterile Liquid Price by Type (2019-2030) & (US$/Unit)

Figure 21. Product Picture of Human Medication

Figure 22. Product Picture of Nutraceuticals

Figure 23. Product Picture of Cosmetics

Figure 24. Product Picture of Medical Devices

Figure 25. Global Non-sterile Liquid Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Non-sterile Liquid Sales Value Market Share by Application, 2023 & 2030

Figure 27. Global Non-sterile Liquid Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 28. Global Non-sterile Liquid Sales Volume Market Share by Application, 2023 & 2030

Figure 29. Global Non-sterile Liquid Price by Application (2019-2030) & (US$/Unit)

Figure 30. North America Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Non-sterile Liquid Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Non-sterile Liquid Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Non-sterile Liquid Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Non-sterile Liquid Sales Volume (%), (2019-2030)

Figure 42. United States Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030

Figure 45. Europe Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030

Figure 48. China Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

Figure 50. China Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030

Figure 51. Japan Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030

Figure 54. South Korea Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030

Figure 57. Southeast Asia Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030

Figure 60. India Non-sterile Liquid Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Non-sterile Liquid Sales Value by Type (%), 2023 VS 2030

Figure 62. India Non-sterile Liquid Sales Value by Application (%), 2023 VS 2030

Figure 63. Non-sterile Liquid Industrial Chain

Figure 64. Non-sterile Liquid Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed